Following U.S. Stocks were among the “Top Gainers” during Monday’s trade: Ambarella Inc (NASDAQ:AMBA), Taubman Centers, Inc (NYSE:TCO), InspireMD Inc (NYSEMKT:NSPR), Theravance Inc (NASDAQ:THRX)
Their insights are depicted underneath:
Ambarella Inc (NASDAQ:AMBA)’s shares picked up 3.25%, and closed at $66.31.
Through GLOBE NEWSWIRE, Ambarella, Inc. (AMBA), a leading developer of low-power, HD video compression and image processing semiconductors, declared financial results for its fiscal fourth quarter and year ended January 31, 2015.
Proceed for the fourth quarter of fiscal 2015 was $64.7 million, up 61.9% from $40.0 million in the same period in fiscal 2014. For the fiscal year ended January 31, 2015, proceed was $218.3 million, up 38.5% from $157.6 million for the year ending January 31, 2014.
Gross margin under U.S. generally accepted accounting principles (GAAP) for the fourth quarter of fiscal 2015 was 64.1%, contrast with 64.0% for the same period in fiscal 2014. For the year ended January 31, 2015, GAAP gross margin was 63.7%, contrast with 63.4% for the year ended January 31, 2014.
GAAP net revenue for the fourth quarter of fiscal 2015 was $17.7 million, or $0.53 per diluted ordinary share, contrast with GAAP net revenue of $5.5 million, or $0.18 per diluted ordinary share, for the same period in fiscal 2014. GAAP net revenue for the year ended January 31, 2015 was $50.6 million, or $1.57 per diluted ordinary share. This compares with GAAP net revenue of $25.7 million, or $0.85 per diluted ordinary share, for the year ended January 31, 2014.
Gross margin on a non-GAAP basis for the fourth quarter of fiscal 2015 was 64.3%, contrast with 64.1% for the same period in fiscal 2014. For the year ended January 31, 2015, non-GAAP gross margin was 63.9%, contrast with 63.5% for the year ended January 31, 2014.
Ambarella reports gross margin, net revenue and earnings per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the influence of stock-based compensation and the associated tax influence. A reconciliation of the GAAP to non-GAAP gross margin, net revenue and earnings per share numbers, in addition to a description of the items excluded from the non-GAAP calculations, is comprised of in the financial statements portion of this press release.
Ambarella, Inc. (AMBA), is a leading developer of low-power, high-definition (HD) and Ultra HD video compression and image processing solutions. The corporation’s products are used in a variety of professional and consumer applications counting security IP-cameras, sports cameras, wearable cameras, flying cameras and automotive video processing solutions. Ambarella compression chips are also used in broadcasting TV programs worldwide.
Taubman Centers, Inc (NYSE:TCO), raised 3.21%, and closed at $74.36.
Taubman Centers, Inc. (TCO), declared that Robert S. Taubman, chairman, president and chief executive officer, and Lisa A. Payne, vice chairman and chief financial officer took part in a corporation roundtable presentation to the investment community at the Citi 2015 Global Property CEO Conference on Monday, March 2, 2015 at 1:35 p.m. EST.
Taubman Centers, Inc. operates as a real estate investment trust. As of June 30, 2005, the corporation owned a 63% managing general partner’s interest in The Taubman Realty Group Limited Partnership (the operating partnership).
InspireMD Inc (NYSEMKT:NSPR), enhanced 3.07%, and closed at $0.299.
InspireMD, Inc. (NSPR), a leader in embolic protection systems (“EPS”), declared the closing of its offering of about 34.4 million shares of ordinary stock and warrants to purchase about 34.4 million shares of ordinary stock. The ordinary stock was sold at a negotiated purchase price of $0.40 per share, and each purchaser received a warrant to purchase one share of ordinary stock for each share of ordinary stock that it purchased in the offering. The warrants are exercisable right away and have a term of exercise of five years from the date of issuance and an exercise price of $0.55 per share. The Corporation received gross proceeds from the offering of about $13.7 million, before deducting placement agents’ fees and estimated offering expenses.
H.C. Wainwright & Co., LLC served as the sole bookrunner for this offering. Dawson James Securities, Inc. served as co-manager.
The Corporation intends to use the net proceeds from this offering to commercially launch CGuard™ EPS, conduct sales activities related to MGuard Prime™ EPS, advance the development of its pipeline, and for general corporate purposes.
InspireMD seeks to utilize its proprietary MGuard® with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
Theravance Inc (NASDAQ:THRX), rose 3.06%, and closed at $20.20.
Theravance Inc. (THRX), declared that Michael W. Aguiar, Theravance’s President and Chief Executive Officer, presented at the Cowen Healthcare Conference on Wednesday, March 4, 2015.
Theravance, Inc., a royalty administration corporation, is focused on developing respiratory products. It receives royalty proceeds RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and VI monotherapy through the Long-Acting Beta2 Agonist partnership contract and the planned alliance contract with Glaxo Group Limited (GSK).
